TM Capital Advises Time-Cap Labs in its Sale to Marksans Pharma
TM Capital is pleased to announce that we served as exclusive financial advisor to Time-Cap Labs, Inc. in its sale to Marksans Pharma Limited (BSE:524404), a global manufacturer and marketer of generic pharmaceuticals based in India.